- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05710510
Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions (RE-TOOL)
Rural Engagement in TelemedTeam for Options in Obesity Treatment Solutions (RE-TOOL)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Obesity increases risk for 13 types of cancer and now affects over 40% of the U.S. adult population, with even higher prevalence among rural Americans. Rural residents often lack access to weight control programs and food and physical activity resources that promote healthy lifestyles, especially in small or remote rural areas. It is important for obesity treatment to be offered in rural primary care, yet local resources are often lacking. Medical management by a primary care provider (PCP) during behavioral weight loss is essential to address co-morbid medical conditions, evaluate obesogenic medications, and explore options for guideline-recommended pharmacotherapy and surgical treatment. This study is designed to enhance sustainable access to obesity treatment in rural communities by offering education to local providers on obesity management and integrating team-based care into an obesity treatment model through telemedicine.
The two methods of obesity treatment to be studied are:
- Local Care + Arm: Quarterly clinic visits with the participants and their local primary care provider
- Team Care Arm: An intensive group lifestyle intervention offered by a lifestyle coach via Zoom, paired with quarterly clinic visits with the participant, their local primary care provider and the lifestyle coach, the coach joining via telemedicine.
Participants will be in the study about 18 months. Participants in the Local Care + arm will be asked to complete 4 data collection visits and 6 quarterly clinic visits. Participants in the Team Care arm will be asked to complete 4 data collection visits, 30 counseling sessions and 6 quarterly clinic visits.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Stacy J McCrea-Robertson, MS
- Phone Number: 9139456941
- Email: smccrea-robertson@kumc.edu
Study Locations
-
-
Missouri
-
Kansas City, Missouri, United States, 66160
- Recruiting
- University of Kansas Medical Center
-
Contact:
- Stacy McCrea-Robertson, MS
- Phone Number: 913-945-6941
- Email: smccrea-robertson@kumc.edu
-
Principal Investigator:
- Christie Befort, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- BMI: >= 30 kg/m2
- Rural resident
- English speaking
- Physician clearance to participate
- Able to walk without assistance
- Seen at least once in their primary care clinic within the past year
- Internet access or smart phone (to access smart scale for weight measurement)
Exclusion Criteria:
- History of myocardial infarction within last six months
- History of stroke within last six months
- History of new cancer diagnosis within last six months
- History of bariatric surgery within the last two years
- Pregnancy within last 6 months or planned within the next 18 months
- Currently breastfeeding
- End stage renal disease, currently on dialysis, or anticipated dialysis or renal transplant within the next 18 months
- End stage liver disease, or anticipated liver transplant within the next 18 months
- Currently enrolled or planning to enroll in another study where weight loss is targeted or weight fluctuation is expected
- Currently planning to move outside of current provider area, or leave primary care clinic within the next 18 months
- Another household member is already participating in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Local Care + Model
Quarterly clinic visits with a local primary care provider
|
Local primary care providers receive training in medical management of obesity prior to the start of the participant intervention. Participants receive 6 quarterly clinic visits with their local primary care provider focused on medical management of obesity. |
Active Comparator: Team Care Model
An intensive group lifestyle intervention led by a lifestyle coach via Zoom, paired with quarterly clinic visits with a local primary care provider and the lifestyle coach, the coach joining via telemedicine.
|
Local primary care providers receive training in medical management of obesity prior to the start of the participant intervention. Participants receive an intensive 18-month group lifestyle intervention (30 total sessions) led by a study lifestyle coach via Zoom, and 6 quarterly 1:1 visits via Zoom with their lifestyle coach. Participants also receive 6 quarterly clinic visits with their local primary care provider; the study lifestyle coach joins the visits via telemedicine. All three parties may meet via telemedicine if needed. The group lifestyle intervention is led by obesity treatment specialists with relevant graduate training and experience. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent weight loss at 18 months
Time Frame: 18 months
|
Mean percent weight loss at 18 months; unadjusted
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent weight loss at 6 months
Time Frame: 6 months
|
Mean percent weight loss at 6 months; unadjusted
|
6 months
|
Percent weight loss at 12 months
Time Frame: 12 months
|
Mean percent weight loss at 12 months; unadjusted
|
12 months
|
Weight loss (kg) at 6 months
Time Frame: 6 months
|
Mean weight loss (kg) at 6 months; unadjusted
|
6 months
|
Weight loss (kg) at 12 months
Time Frame: 12 months
|
Mean weight loss (kg) at 12 months; unadjusted
|
12 months
|
Weight loss (kg) at 18 months
Time Frame: 18 months
|
Mean weight loss (kg) at 18 months; unadjusted
|
18 months
|
Proportion achieving ≥5% weight loss at 6 months
Time Frame: 6 months
|
Proportion achieving ≥5% weight loss at 6 months; unadjusted
|
6 months
|
Proportion achieving ≥5% weight loss at 12 months
Time Frame: 12 months
|
Proportion achieving ≥5% weight loss at 12 months; unadjusted
|
12 months
|
Proportion achieving ≥5% weight loss at 18 months
Time Frame: 18 months
|
Proportion achieving ≥5% weight loss at 18 months; unadjusted
|
18 months
|
Proportion achieving ≥10% weight loss at 6 months
Time Frame: 6 months
|
Proportion achieving ≥10% weight loss at 6 months; unadjusted
|
6 months
|
Proportion achieving ≥10% weight loss at 12 months
Time Frame: 12 months
|
Proportion achieving ≥10% weight loss at 12 months; unadjusted
|
12 months
|
Proportion achieving ≥10% weight loss at 18 months
Time Frame: 18 months
|
Proportion achieving ≥10% weight loss at 18 months; unadjusted
|
18 months
|
Change in diet quality at 6 months
Time Frame: Baseline and 6 months
|
Mean change in diet quality, measured by Rapid Eating Assessment for Participant--Shortened Version (REAPS) at 6 months; unadjusted.
The REAPS estimates diet quality through 13 items which assess weekly eating habits.
Possible scores range from 13 (worst diet quality) to 39 (best diet quality).
|
Baseline and 6 months
|
Change in diet quality at 12 months
Time Frame: Baseline and 12 months
|
Mean change in diet quality, measured by Rapid Eating Assessment for Participant--Shortened Version (REAPS) at 12 months; unadjusted.
The REAPS estimates diet quality through 13 items which assess weekly eating habits.
Possible scores range from 13 (worst diet quality) to 39 (best diet quality).
|
Baseline and 12 months
|
Change in diet quality at 18 months
Time Frame: Baseline and 18 months
|
Mean change in diet quality, measured by Rapid Eating Assessment for Participant--Shortened Version (REAPS) at 18 months; unadjusted.
The REAPS estimates diet quality through 13 items which assess weekly eating habits.
Possible scores range from 13 (worst diet quality) to 39 (best diet quality).
|
Baseline and 18 months
|
Change in physical activity at 6 months
Time Frame: Baseline and 6 months
|
Mean change in MET-HOURS per week measured by Modifiable Activity Questionnaire (MAQ) at 6 months; unadjusted.
The MAQ will be used to measure participants' leisure-time physical activity over the past 7 days.
Leisure-time physical activity will be calculated as the Metabolic Equivalent of Task (MET) hours per week (MET-hr/week) and estimated by multiplying time (in hours) spent in an activity by the activities estimated MET and summing across all activities.
|
Baseline and 6 months
|
Change in physical activity at 12 months
Time Frame: Baseline and 12 months
|
Mean change in MET-HOURS per week measured by Modifiable Activity Questionnaire (MAQ) at 12 months; unadjusted.
The MAQ will be used to measure participants' leisure-time physical activity over the past 7 days.
Leisure-time physical activity will be calculated as the Metabolic Equivalent of Task (MET) hours per week (MET-hr/week) and estimated by multiplying time (in hours) spent in an activity by the activities estimated MET and summing across all activities.
|
Baseline and 12 months
|
Change in physical activity at 18 months
Time Frame: Baseline and 18 months
|
Mean change in MET-HOURS per week measured by Modifiable Activity Questionnaire (MAQ) at 18 months; unadjusted.
The MAQ will be used to measure participants' leisure-time physical activity over the past 7 days.
Leisure-time physical activity will be calculated as the Metabolic Equivalent of Task (MET) hours per week (MET-hr/week) and estimated by multiplying time (in hours) spent in an activity by the activities estimated MET and summing across all activities.
|
Baseline and 18 months
|
Change in physical quality of life at 6 months
Time Frame: Baseline and 6 months
|
Mean change in physical quality of life, measured by SF-12 at 6 months; unadjusted.
The Short Form Health Survey (SF-12) is a general quality of life measure with a physical functioning summary score.
Scores range from 0 to 100 with higher scores representing better functioning.
|
Baseline and 6 months
|
Change in physical quality of life at 12 months
Time Frame: Baseline and 12 months
|
Mean change in physical quality of life, measured by SF-12 at 12 months; unadjusted.
The Short Form Health Survey (SF-12) is a general quality of life measure with a physical functioning summary score.
Scores range from 0 to 100 with higher scores representing better functioning.
|
Baseline and 12 months
|
Change in physical quality of life at 18 months
Time Frame: Baseline and 18 months
|
Mean change in physical quality of life, measured by SF-12 at 18 months; unadjusted.
The Short Form Health Survey (SF-12) is a general quality of life measure with a physical functioning summary score.
Scores range from 0 to 100 with higher scores representing better functioning.
|
Baseline and 18 months
|
Change in mental quality of life at 6 months
Time Frame: Baseline and 6 months
|
Mean change in mental quality of life, measured by SF-12 at 6 months; unadjusted.
The Short Form Health Survey (SF-12) is a general quality of life measure with a mental functioning summary score.
Scores range from 0 to 100 with higher scores representing better functioning.
|
Baseline and 6 months
|
Change in mental quality of life at 12 months
Time Frame: Baseline and 12 months
|
Mean change in mental quality of life, measured by SF-12 at 12 months; unadjusted.
The Short Form Health Survey (SF-12) is a general quality of life measure with a mental functioning summary score.
Scores range from 0 to 100 with higher scores representing better functioning.
|
Baseline and 12 months
|
Change in mental quality of life at 18 months
Time Frame: Baseline and 18 months
|
Mean change in mental quality of life, measured by SF-12 at 18 months; unadjusted.
The Short Form Health Survey (SF-12) is a general quality of life measure with a mental functioning summary score.
Scores range from 0 to 100 with higher scores representing better functioning.
|
Baseline and 18 months
|
Change in weight-related quality of life at 6 months
Time Frame: Baseline and 6 months
|
Mean change in total quality of life, measured by Impact of Weight on Quality of Life-Lite (IWQOL-L) at 6 months; unadjusted.
The IWQOL-L measure consists of a total score and five subscales--physical function, self-esteem, sexual life, public distress, and work.
The total score ranges from 0 to 100 with higher scores indicating better quality of life.
|
Baseline and 6 months
|
Change in weight-related quality of life at 12 months
Time Frame: Baseline and 12 months
|
Mean change in total quality of life, measured by Impact of Weight on Quality of Life-Lite (IWQOL-L) at 12 months; unadjusted.
The IWQOL-L measure consists of a total score and five subscales--physical function, self-esteem, sexual life, public distress, and work.
The total score ranges from 0 to 100 with higher scores indicating better quality of life.
|
Baseline and 12 months
|
Change in weight-related quality of life at 18 months
Time Frame: Baseline and 18 months
|
Mean change in total quality of life, measured by Impact of Weight on Quality of Life-Lite (IWQOL-L) at 18 months; unadjusted.
The IWQOL-L measure consists of a total score and five subscales--physical function, self-esteem, sexual life, public distress, and work.
The total score ranges from 0 to 100 with higher scores indicating better quality of life.
|
Baseline and 18 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Christie Befort, PhD, University of Kansas Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00147574
- 1R01CA268034-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuNot yet recruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Local Care + Model
-
Harvard School of Public Health (HSPH)RecruitingCardiovascular Diseases (CVD)Argentina
-
Showa UniversityIndonesia UniversityUnknownPregnant Women | Preterm Delivery | Antenatal Care ModelIndonesia
-
Federal University of Rio Grande do SulCompletedPatellofemoral Pain SyndromeBrazil
-
Massachusetts General HospitalActive, not recruitingType 1 Diabetes | Type 2 DiabetesUnited States
-
University Health Network, TorontoCompleted
-
Indiana UniversityWalther Cancer Institute; Charles Warren Fairbanks Center for Medical EthicsCompletedCancer | Coping Skills
-
Duke UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); New...CompletedDiabetes MellitusUnited States
-
Baqiyatallah Medical Sciences UniversityShahid Beheshti University; Tehran University of Medical SciencesCompletedAcute Respiratory Distress Syndrome | Tobacco; Use, Rehabilitation
-
Nationwide Children's HospitalCompletedLow Back Pain | Spondylolisthesis | SpondylolysisUnited States
-
Brigham and Women's HospitalRecruitingHypertensionSouth Africa